Epithelial barrier dysfunction in chronic respiratory diseases

FM Carlier, C de Fays, C Pilette - Frontiers in physiology, 2021 - frontiersin.org
Mucosal surfaces are lined by epithelial cells, which provide a complex and adaptive
module that ensures first-line defense against external toxics, irritants, antigens, and …

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD

C Janson, G Stratelis, A Miller-Larsson… - … journal of chronic …, 2017 - Taylor & Francis
Inhaled corticosteroids (ICSs) treatment combined with long-acting β2-adrenoceptor
agonists (LABAs) reduces the risk of exacerbations in COPD, but the use of ICSs is …

Across the pulmonary epithelial barrier: Integration of physicochemical properties and human cell models to study pulmonary drug formulations

M Haghi, HX Ong, D Traini, P Young - Pharmacology & therapeutics, 2014 - Elsevier
During the process of inhalable formulation development a deep knowledge of the
physicochemical characteristics of the drug and formulation components and the biological …

[HTML][HTML] In vitro investigation on the impact of airway mucus on drug dissolution and absorption at the air-epithelium interface in the lungs

E Cingolani, S Alqahtani, RC Sadler, D Prime… - European Journal of …, 2019 - Elsevier
Although the mucus layer is the first biological barrier encountered by inhaled drugs upon
their deposition in the upper airways, its potential impact on drug dissolution and absorption …

Bulk to nanometer-scale infrared spectroscopy of pharmaceutical dry powder aerosols

D Khanal, J Zhang, WR Ke, MM Banaszak Holl… - Analytical …, 2020 - ACS Publications
Solid state chemical analysis of pharmaceutical inhalation aerosols at the individual particle
level has been an analytical challenge. These particles can range from a few nanometers to …

Investigations on the mechanism of magnesium stearate to modify aerosol performance in dry powder inhaled formulations

MW Jetzer, M Schneider, BD Morrical… - Journal of pharmaceutical …, 2018 - Elsevier
The potential of the force control agent magnesium stearate (MgSt) to enhance the aerosol
performance of lactose-based dry powder inhaled (DPI) formulations was investigated in this …

Permeation of therapeutic drugs in different formulations across the airway epithelium in vitro

C Meindl, S Stranzinger, N Dzidic, S Salar-Behzadi… - PLoS …, 2015 - journals.plos.org
Background Pulmonary drug delivery is characterized by short onset times of the effects and
an increased therapeutic ratio compared to oral drug delivery. This delivery route can be …

[PDF][PDF] Towards standardized dissolution techniques for in vitro performance testing of dry powder inhalers

A Floroiu, M Klein, J Krämer, CM Lehr - Dissolution Technol, 2018 - dissolutiontech.com
The pulmonary route of administration is used for both locally and systemically acting drugs.
However, knowledge gaps about the fate of aerosol particles after deposition in the lung …

Pulmonary in vitro instruments for the replacement of animal experiments

D Primavessy, J Metz, S Schnur, M Schneider… - European Journal of …, 2021 - Elsevier
Advanced in vitro systems often combine a mechanical-physical instrument with a biological
component eg cell culture models. For testing of aerosols, it is of advantage to consider …

In Vitro Cell Integrated Impactor Deposition Methodology for the Study of Aerodynamically Relevant Size Fractions from Commercial Pressurised Metered Dose …

M Haghi, D Traini, P Young - Pharmaceutical research, 2014 - Springer
Purpose The purpose of this study was to present a modified Andersen cascade impactor
(ACI) as a platform to evaluate the deposition and subsequent transport of aerosol …